A 6‐bp Deletion Variant in a Novel Canine Glutathione‐S‐Transferase Gene (GSTT5) Leads to Loss of Enzyme Function

por Craft, S., Ekena, J., Sacco, J., Luethcke, K., Trepanier, L.
Publicado 2017

The deubiquitylase Ataxin-3 restricts PTEN transcription in lung cancer cells

por Sacco, J J, Yau, T Y, Darling, S, Patel, V, Liu, H, Urbé, S, Clague, M J, Coulson, J M
Publicado 2014

A75 COLONOSCOPY COLORECTAL CANCER DETECTION - HOW DOES IT VARY BY INDICATION, SETTING AND PATIENT DEMOGRAPHIC?

por Dube, C, McCurdy, B R, Sacco, J, Gao, J, Silveira, K, Karapetyan, T, Niu, Y, Tinmouth, J
Publicado 2023

Congenital Methemoglobinemia in a Dog with a Promoter Deletion and a Nonsynonymous Coding Variant in the Gene Encoding Cytochrome b (5)

por McKenna, J.A., Sacco, J., Son, T.T., Trepanier, L.A., Callan, M.B., Harvey, J.W., Arndt, J.W.
Publicado 2014

Altered Nuclear Expression of the Deubiquitylase BAP1 Cannot be Used as a Prognostic Marker for Canine Melanoma

por Jama, N., Farquhar, N., Butt, Z., Coupland, S.E., Sacco, J.J., Scase, T., Fielding, A.B., Coulson, J.M., Kalirai, H., Killick, D.R.
Publicado 2018

922P EACH: A phase II study evaluating the safety and anti-tumour activity of avelumab and cetuximab in recurrent/metastatic squamous cell carcinomas

por Forster, M., Metcalf, R., Sacco, J., Kong, A., Wheeler, G., Forsyth, S., Bhat, R., Blair, K., Ward, J., Lowe, H., Spanswick, V., Ensell, L., Hartley, J., White, L.
Publicado 2020

Looking a Gift Horse in the Mouth: Observations on NHS England's Interim Guidance on Pembrolizumab in Head and Neck Squamous Cell Cancer

por Harrington, K.J., Bhide, S.A., Forster, M.D., Good, J.S., Gunn, L., Kong, A., Melcher, A.A., Metcalf, R., Nenclares, P., Newbold, K.L., Nutting, C.M., Prestwich, R., Sacco, J.J., Soliman, H., Wong, K.H.
Publicado 2020